Industry Insight
The Newtropin Blog
Articles, clinical notes, regulatory updates, and product deep-dives — written for physicians running wellness practices.
Featured
What Telehealth Providers Need to Know About Compounded Medications
Dual-licensure rules, controlled substances, cold chain, and the compounding constraints telehealth prescribers hit that in-person practices don't.
Newtropin Team · August 30, 2026
Read article →
Telehealth Peptide Prescriptions: How It Works With a Licensed Provider
Newtropin Team · Aug 28, 2026
Top 10 HRT Providers in 2026
Newtropin Team · Aug 27, 2026
Top 10 TRT Providers in 2026
Newtropin Team · Aug 27, 2026
Why Anti-Aging Clinics Are Adding Peptide Therapy to Their Menu
Newtropin Team · Aug 27, 2026
Top 10 Compounding Pharmacies for Retatrutide (2026)
Newtropin Team · Aug 26, 2026
Private Label Supplements: The ROI for Medical Practices
Newtropin Team · Aug 25, 2026
Peptide and Hormone Therapy for Menopause Symptoms: What's Available
Newtropin Team · Aug 24, 2026
Building a Weight Loss Program with Compounded GLP-1s: A Practice Guide
Newtropin Team · Aug 23, 2026
What Determines Peptide Therapy Cost? Pricing Factors and Insurance
Newtropin Team · Aug 21, 2026
Compounding Pharmacy Compliance: What to Verify Before You Prescribe
Newtropin Team · Aug 20, 2026
How to Start Peptide Therapy: Consultation, Prescription and Sourcing
Newtropin Team · Aug 19, 2026
Revenue Diversification: How Peptide Therapy Grows a Wellness Practice
Newtropin Team · Aug 18, 2026
The Pentagon Is Screening Troops for Low Testosterone — Where Peptides Fit the Hormone-Optimization Moment
Newtropin Team · Jul 16, 2026
FDA Publishes All 7 Briefing Documents Ahead of the July 2026 PCAC Meeting
Newtropin Team · Jul 1, 2026
BPC-157 Before the FDA: Briefing Document Focuses on Ulcerative Colitis
Newtropin Team · Jul 1, 2026
FDA 503A Update: What the July 2026 PCAC Peptide Decision Means for Compounders and Physicians
Newtropin Team · Jul 1, 2026
TB-500 and Wound Healing: What the FDA Briefing Document Signals
Newtropin Team · Jul 1, 2026
KPV Under FDA Review for Wound Healing and Inflammatory Conditions
Newtropin Team · Jul 1, 2026
BPC-157 and the FDA 503A Decision: Why FDA Is Proposing Not to List the Peptide
Newtropin Team · Jun 30, 2026
KPV and the FDA 503A Decision: The α-MSH Fragment FDA Declined to List
Newtropin Team · Jun 29, 2026
TB-500 and the FDA 503A Decision: The Thymosin β-4 Fragment FDA Declined to List
Newtropin Team · Jun 28, 2026
MOTS-c and the FDA 503A Decision: The Mitochondrial Peptide FDA Declined to List
Newtropin Team · Jun 27, 2026
Emideltide (Delta Sleep-Inducing Peptide) and the FDA 503A Decision
Newtropin Team · Jun 26, 2026
Epitalon and the FDA 503A Decision: The Pineal Tetrapeptide FDA Declined to List
Newtropin Team · Jun 25, 2026
Semax and the FDA 503A Decision: The ACTH-Fragment Neuropeptide FDA Declined to List
Newtropin Team · Jun 24, 2026
FDA 503A Peptide Update 2026: What It Means for Patients
Newtropin Team · Jun 17, 2026
Is BPC-157 Legal in 2026? FDA Compounding Status Explained
Newtropin Team · Jun 17, 2026
Is TB-500 Legal? FDA's July 2026 Decision Explained
Newtropin Team · Jun 17, 2026
Epitalon FDA Status 2026: What It Means for Anti-Aging Peptide Therapy
Newtropin Team · Jun 17, 2026
DSIP (Emideltide) FDA Update: Sleep Peptide Moves Closer to Legal Compounding
Newtropin Team · Jun 16, 2026
5 Peptides the FDA Is Reviewing in July 2026 (And What to Expect)
Newtropin Team · Jun 16, 2026
What Is a PCAC Meeting? How the FDA Decides Which Peptides Can Be Compounded
Newtropin Team · Jun 16, 2026
BPC-157, TB-500, Semax and MOTs-C: The July 2026 FDA Review Explained
Newtropin Team · Jun 16, 2026
Which Peptides Are Legal to Compound in 2026? Full FDA Status Guide
Newtropin Team · Jun 15, 2026
GHK-Cu FDA Status and Compounding Update 2026: What Anti-Aging Patients Should Know
Newtropin Team · Jun 15, 2026
Semax FDA Status 2026: Is This Cognitive Peptide Heading to Legal Compounding?
Newtropin Team · Jun 15, 2026
Top 15 Compounding Pharmacies for Semaglutide & GLP-1 Therapy (2026)
Newtropin Team · Jun 14, 2026
Top 10 Compounding Pharmacies for Peptide Therapy (2026)
Newtropin Team · Jun 14, 2026
Top 15 Compounding Pharmacies for Hormone Replacement Therapy (2026)
Newtropin Team · Jun 14, 2026
Top 10 Compounding Pharmacies That Ship Nationwide (2026)
Newtropin Team · Jun 14, 2026
Top 20 Best Online Compounding Pharmacies (2026)
Newtropin Team · Jun 13, 2026
Top 10 Compounding Pharmacies for BPC-157 & TB-500 (2026)
Newtropin Team · Jun 13, 2026
Top 10 Compounding Pharmacies for Anti-Aging Peptides (2026)
Newtropin Team · Jun 13, 2026
Top 10 Compounding Pharmacies for Men's Health & TRT (2026)
Newtropin Team · Jun 13, 2026
Top 10 Compounding Pharmacies for Women's Health (2026)
Newtropin Team · Jun 12, 2026
Top 10 Compounding Pharmacies for Pain Management (2026)
Newtropin Team · Jun 12, 2026
Top 10 USP 800-Compliant Compounding Pharmacies (2026)
Newtropin Team · Jun 12, 2026
Top 10 PCAB-Accredited Compounding Pharmacies (2026)
Newtropin Team · Jun 12, 2026
Top 10 Compounding Pharmacies for Veterinary Medicine (2026)
Newtropin Team · Jun 11, 2026
Top 15 Compounding Pharmacies for Dermatology (2026)
Newtropin Team · Jun 11, 2026
Top 10 503B Outsourcing Facilities vs 503A Compounding Pharmacies: Understanding the Difference (2026)
Newtropin Team · Jun 11, 2026
Semax FDA Status 2026: Is This Cognitive Peptide Heading to Legal Compounding?
Newtropin · May 25, 2026
GHK-Cu FDA Status and Compounding Update 2026: What Anti-Aging Patients Should Know
Newtropin · May 25, 2026
Which Peptides Are Legal to Compound in 2026? Full FDA Status Guide
Newtropin · May 25, 2026
BPC-157, TB-500, Semax and MOTs-C: The July 2026 FDA Review Explained
Newtropin · May 25, 2026
What Is a PCAC Meeting? How the FDA Decides Which Peptides Can Be Compounded
Newtropin · May 25, 2026
5 Peptides the FDA Is Reviewing in July 2026 (And What to Expect)
Newtropin · May 25, 2026
DSIP (Emideltide) FDA Update: Sleep Peptide Moves Closer to Legal Compounding
Newtropin · May 25, 2026
Epitalon FDA Status 2026: What It Means for Anti-Aging Peptide Therapy
Newtropin · May 25, 2026
Is TB-500 Legal? FDA’s July 2026 Decision Explained
Newtropin · May 25, 2026
Is BPC-157 Legal in 2026? FDA Compounding Status Explained
Newtropin · May 25, 2026
FDA 503A Peptide Update 2026: What It Means for Patients
Newtropin · May 25, 2026
Top 3 Peptides for Women’s Hormonal Balance | Newtropin
Newtropin · May 18, 2026
5 Reasons CJC-1295 + Ipamorelin Is the Most Popular Peptide Stack | Newtropin
Newtropin · May 17, 2026
HGH vs. Peptides: 7 Things Every Patient Should Know | Newtropin
Newtropin · May 16, 2026
Semaglutide vs. Peptides: 5 Key Differences You Should Know | Newtropin
Newtropin · May 15, 2026
10 Questions to Ask Before Starting Peptide Therapy | Newtropin
Newtropin · May 14, 2026
7 Best Peptides for Muscle Repair (BPC-157, TB-500 & More) | Newtropin
Newtropin · May 13, 2026
Top 5 Peptides for Men Over 40 | Newtropin
Newtropin · May 12, 2026
9 Best Peptides for Sleep and Recovery | Newtropin
Newtropin · May 10, 2026
8 Peptides That Actually Work for Anti-Aging (Science-Backed) | Newtropin
Newtropin · May 9, 2026
5 Best Peptide Stacks for Weight Loss and Muscle Gain | Newtropin
Newtropin · May 7, 2026
7 Signs You Need Growth Hormone Therapy (And What to Do Next) | Newtropin
Newtropin · May 6, 2026
10 Best Peptides for Fat Loss (Ranked by Results) | Newtropin
Newtropin · May 5, 2026
Private Label Weight Loss Supplements for GLP-1 and Peptide Clinics
Newtropin · May 4, 2026
Private Label Nutraceuticals for Medical Practices: A Launch Playbook
Newtropin · May 4, 2026
Top Private Label Supplement Manufacturers in the US (2026): A Clinician’s Comparison
Newtropin · May 4, 2026
Top Compounding Pharmacies in the US for Peptide Therapy: 2026 Edition
Newtropin · May 4, 2026
How to Choose a Compounding Pharmacy for Peptides: Quality Markers, Red Flags, and Questions to Ask
Newtropin · May 4, 2026
Which USP Chapters Are Enforceable by Law? A Compliance Prime
Newtropin · May 3, 2026
USP 795, 797, 800 Explained: What Every Compounding Pharmacy Partner Should Demonstrate
Newtropin · May 3, 2026
FDA-Approved Peptides List 2026: A Physician’s Regulatory Landscape
Newtropin · May 3, 2026
503A vs 503B Compounding Pharmacies: Which One Your Practice Needs
Newtropin · May 3, 2026
PCAC July 2026 Meeting: What Physicians Should Watch for on Compounding Peptides
Newtropin · May 3, 2026
The FDA 503A Bulk Drug Substances List: Current Peptide Status (April 2026 Update)
Newtropin · May 3, 2026
Natural GLP-1 Support: Supplements and Peptide Alternatives for Weight Management
Newtropin · May 3, 2026
Compounded Tirzepatide in 2026: Sourcing, Legality, and What to Tell Patients
Newtropin · May 3, 2026
Semaglutide vs Tirzepatide vs Retatrutide: Weight Loss Percentages and Mechanisms Compared
Newtropin · May 3, 2026
Retatrutide Through Compounding Pharmacies in 2026: Access, Legality, and Clinical Positioning
Newtropin · May 3, 2026
GHK-Cu Contraindications and Safety: Zinc Depletion, Wilson’s Disease, and Metallic Taste
Newtropin · May 3, 2026
Enclomiphene in 2026: FDA Approval for Male Hypogonadism, Kisspeptin Stacks, and Practice Use
Newtropin · May 3, 2026
Methylene Blue + NMN: Clinical Rationale, Evidence, and Stacking Considerations
Newtropin · May 3, 2026
Methylene Blue Mechanism of Action: Mitochondrial Electron Transport and Redox Cycling
Newtropin · May 3, 2026
Follistatin-344: Muscle, Myostatin, and Hair Growth Applications
Newtropin · May 3, 2026
AOD-9604 (HGH Fragment 177-191): Lipolysis Without Growth Hormone Effects
Newtropin · May 3, 2026
5-Amino-1MQ Side Effects: Heart Rate, Appetite, and Emerging Safety Data
Newtropin · May 3, 2026
5-Amino-1MQ Human Clinical Trials: 2026 Status and Fat Loss Mechanism
Newtropin · May 3, 2026
TB-500 Half-Life, Sequence, and Dosing: A Physician’s Quick Reference
Newtropin · May 3, 2026
TB-500 (Thymosin Beta-4 Fragment): Actin Regulation, Cell Migration, and Tissue Repair
Newtropin · May 3, 2026
Epitalon Research Deep Dive: Neuroprotection, Epigenetics, and Geroprotective Effects
Newtropin · May 3, 2026
Epitalon Side Effects and Contraindications: Vivid Dreams, Pregnancy, and the Cancer Question
Newtropin · May 3, 2026
Epitalon FDA Approval Status 2026: Category 2 Position and Compounding Access
Newtropin · May 3, 2026
Epitalon: The Longevity Peptide, Telomerase Activation, and Theoretical Cancer Risk Explained
Newtropin · May 3, 2026
KPV Half-Life, Dosing, and Sleep Benefits: Practitioner Quick Reference
Newtropin · May 3, 2026
KPV for Gastrointestinal and Dermatological Inflammation: Clinical Research Summary
Newtropin · May 3, 2026
KPV Tripeptide: α-MSH Fragment, Mechanism, and Anti-Inflammatory Research
Newtropin · May 3, 2026
Ipamorelin Nasal Spray: Dosing, Effectiveness, and Where to Source It
Newtropin · May 3, 2026
CJC-1295 vs Tesamorelin for Visceral Fat: Choosing the Right GHRH Analog
Newtropin · May 3, 2026
CJC-1295 / Ipamorelin Body Composition Data: What the Clinical Evidence Actually Shows
Newtropin · May 3, 2026
CJC-1295 + Ipamorelin: Oral Spray vs Nasal vs Injection — Bioavailability, Delivery, and Practice Fit
Newtropin · May 2, 2026
BPC-157 Clinical Research Review: Preclinical Tissue Repair and Emerging Human Data
Newtropin · May 2, 2026
BPC-157 After the April 2026 FDA Bulk Drug Substances Update
Newtropin · May 2, 2026
BPC-157 Mechanism of Action: Angiogenesis, Nitric Oxide, and Anti-Inflammatory Pathways
Newtropin · May 2, 2026
BPC-157: What Is the Gastric-Derived Pentadecapeptide? Origin, Structure, and Mechanism
Newtropin · May 2, 2026
SLU-PP-332 vs MOTS-c: Comparing Exercise Mimetics for Metabolic Medicine
Newtropin · May 2, 2026
SLU-PP-332 FDA Approval Status and 2026 Regulatory Outlook
Newtropin · May 2, 2026
SLU-PP-332 Phase 1 Human Trial: Status, Timeline, and What ClinicalTrials.gov Shows
Newtropin · May 2, 2026
SLU-PP-332 and Heart Rate: Understanding the Tachycardia Signal
Newtropin · May 2, 2026
SLU-PP-332 Explained: What the ERR Agonist Exercise Mimetic Does
Newtropin · May 2, 2026
Testagen Peptide Side Effects and Clinical Monitoring
Newtropin · May 2, 2026
Testagen Dosage and Protocol Guide for Clinicians
Newtropin · May 2, 2026
Testagen for Women: Peptide Bioregulators and Female Hormone Balance
Newtropin · May 2, 2026
Testagen vs Testosterone (TRT): Why Peptide Bioregulators Work Differently
Newtropin · May 2, 2026
What Is Testagen? A Physician’s Guide to the Testes Peptide Bioregulator
Newtropin · May 2, 2026
FDA Removes 12 Peptides from 503A Category 2
Newtropin · Apr 15, 2026
Top 10 Nutraceutical Private Label Companies in 2026: Expert Rankings for Healthcare Practices
Newtropin · Feb 18, 2026
Top 10 Compounding Pharmacies in 2026: Expert Rankings & Reviews
Newtropin · Feb 18, 2026
Working with Compounding Pharmacies: Provider & Patient Guide
Newtropin · Feb 18, 2026
How to Choose a Quality Compounding Pharmacy: Red Flags & Verification
Newtropin · Feb 18, 2026
Clinical Applications of Compound Pharmacies: From Hormones to Peptides
Newtropin · Feb 18, 2026
USP Standards for Compounding Pharmacies: 795, 797 & 800 Explained
Newtropin · Feb 18, 2026
503A Compounding Pharmacies: Complete Guide to Custom Medication Solutions
Newtropin · Feb 18, 2026
Weight Loss Peptide Safety Guide: Side Effects, Monitoring & Medical Supervision
Newtropin · Feb 16, 2026
Custom Weight Loss Peptide Protocols: Combining Peptides for Maximum Results
Newtropin · Feb 16, 2026
Emerging Weight Loss Peptides: Tesofensine, 5-Amino-1MQ & Novel Compounds
Newtropin · Feb 16, 2026
Growth Hormone Peptides for Fat Loss: CJC-1295, Ipamorelin, Tesamorelin & AOD 9604
Newtropin · Feb 16, 2026
GLP-1 Weight Loss Peptides: Complete Guide to Semaglutide, Tirzepatide & Retatrutide
Newtropin · Feb 16, 2026
Complete Guide to Weight Loss Peptides: GLP-1s, Growth Hormone Peptides & Beyond
Newtropin · Feb 16, 2026
The Science Behind Weight Management Peptides: More Than Just GLP-1s
Newtropin · Feb 16, 2026
Topical Compounding: Custom Solutions for Hair Loss, Pain Relief, and Skin Health
Newtropin · Feb 16, 2026
State Licensing & Pharmacy Regulations: What Patients Need to Know
Newtropin · Feb 16, 2026
IV Nutritional Therapy & Injectable Wellness: Beyond Traditional Supplementation
Newtropin · Feb 16, 2026
Bioidentical Hormone Replacement Therapy: A Compounding Pharmacy Perspective
Newtropin · Feb 16, 2026
The Rise of Personalized Medicine: How Compounding Pharmacies Enable Customized Treatment
Newtropin · Feb 16, 2026
GLP-1 Medications: Compounded vs. Commercial Options
Newtropin · Feb 16, 2026
Peptide Therapy 101: A Comprehensive Guide to Compounded Peptides
Newtropin · Feb 16, 2026
Somatropin + IGF-1 LR3 Oral Spray: Comprehensive GH/IGF Axis Support
Newtropin · Feb 12, 2026
Happy SAC: Comprehensive HPG Axis Support Through Multi-Peptide Sublingual Delivery
Newtropin · Feb 12, 2026
Gym Gazelle: Triple-Compound Metabolic Performance Enhancement
Newtropin · Feb 11, 2026
SLU-PP-332: The Exercise Mimetic Revolutionizing Metabolic Medicine
Newtropin · Feb 11, 2026
GLP Busters: Natural GLP-1 Support for Comprehensive Weight Management
Newtropin · Feb 10, 2026
Glad Gonads: Natural Testosterone and Fertility Support Through HPG Axis Stimulation
Newtropin · Feb 10, 2026
GHRP-2 Matrix: Comprehensive Growth Hormone and Amino Acid Support for Performance Medicine
Newtropin · Feb 10, 2026
GHRH Mouth Spray: Stimulating Natural Growth Hormone for Longevity Medicine
Newtropin · Feb 10, 2026
GHK-Cu: The Copper Peptide Revolutionizing Regenerative and Anti-Aging Medicine
Newtropin · Feb 10, 2026
Follistatin 344: Myostatin Inhibition for Muscle, Performance, and Regenerative Medicine
Newtropin · Feb 10, 2026
Flaco Drops 6C: Advanced Multi-Peptide Weight Management for Modern Medical Practice
Newtropin · Feb 10, 2026
Epitalon: The Longevity Peptide Revolutionizing Anti-Aging Medicine
Newtropin · Feb 10, 2026
Enclomiphene: Fertility-Preserving Testosterone Optimization for Male Hypogonadism
Newtropin · Feb 10, 2026
D-SIP Sleep Peptide Spray: Clinical Sleep Support for Modern Medical Practice
Newtropin · Feb 10, 2026
DIM Complex: Advanced Hormone Metabolism Support for Anti-Aging Medicine
Newtropin · Feb 10, 2026
Clear Skies: Advanced Neuroprotective Formula for Cognitive Health and Longevity
Newtropin · Jan 30, 2026
CJC-1295 + Ipamorelin Oral Spray: Innovation in Growth Hormone Optimization
Newtropin · Jan 30, 2026
Chisel Drops: Advanced Anabolic Support for Body Composition and Performance Optimization
Newtropin · Jan 30, 2026
Chillax™ 6C Homeopathic Oral Spray: Clinical Applications for Stress and Anxiety Support
Newtropin · Jan 30, 2026
Brain Health Support: A Physician’s Guide to Cognitive Optimization with NMN, NAC, and CB-4211
Newtropin · Jan 30, 2026
BPC-157: The Body Protective Compound Revolutionizing Regenerative Medicine
Newtropin · Jan 30, 2026
Boca Trimm: A Physician’s Guide to Synergistic Weight Management and Metabolic Optimization
Newtropin · Jan 30, 2026
Bello Capello: Clinical Applications of Oral Minoxidil and Biotin for Hair Regrowth
Newtropin · Jan 28, 2026
AOD-9604 Peptide: A Physician’s Guide to Growth Hormone Fragment for Medical Weight Loss
Newtropin · Jan 28, 2026
AMORE-MIO Peptide Spray: Clinical Applications for Sexual Wellness in Anti-Aging and Functional Medicine
Newtropin · Jan 28, 2026
Want this delivered to your inbox?
Quarterly research summaries and clinical updates — no spam, no sales pitches.